Award
National Cancer Institute 1UG3CA311138-01
High Throughput Screening of Natural Compounds for Breast Cancer Prevention
Recipient
University of Kansas Medical Center
Award Amount
$325,454.00
Ceiling
$325,454.00
Awarded
July 07, 2026
Identifier
1UG3CA311138-01
Award for research on breast cancer prevention through screening natural compounds targeting BCL9 and β-catenin interaction, including assay development and in vivo testing.
Description
This project involves high throughput screening of natural compounds for breast cancer prevention, focusing on targeting BCL9 interaction with β-catenin. It includes assay development, mechanistic studies, pharmacokinetics, and in vivo efficacy testing. Funded by the National Cancer Institute with a total amount of $325,454 for fiscal year 2026.